Q2 2022 Earnings

Investor Relations

Press Releases

04 Aug '22
Second quarter bookings of $107 million and $172 million year-to-date, up 10% from the first half of 2021 Generated $42 million of cash flow from continuing operations in the quarter CHICAGO --(BUSINESS WIRE)--Aug. 4, 2022-- Allscripts Healthcare Solutions, Inc.
21 Jul '22
CHICAGO --(BUSINESS WIRE)--Jul. 21, 2022-- Allscripts Healthcare Solutions, Inc . (NASDAQ: MDRX) will report its financial results for the three months ended June 30, 2022 after the close of stock market hours on Thursday, August 4, 2022 . Allscripts management plans to host a conference call and
29 Jun '22
Veradigm is providing health plans with a patent-protected method to support risk adjustment programs through “Dynamic Intervention Planning” CHICAGO --(BUSINESS WIRE)--Jun. 29, 2022-- Veradigm, a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that its method and

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
Jenny.Gelinas@allscripts.com